Objectives To investigate the survival of apremilast in a cohort of psoriasis patients treated
with apremilast in a Greek hospital. Methods A retrospective cross-sectional study examined …

There is limited evidence about the real‐world survival of apremilast in patients with
psoriasis, especially over the long term. To evaluate the long‐term survival of apremilast and …

DEAR EDITOR, Apremilast has demonstrated a favourable safety profile for the treatment of
psoriasis based on its pivotal randomized controlled trials (RCTs), ESTEEM 1 and 2. 1, 2 …

Apremilast has been approved as an effective and safe treatment for psoriasis, but clinical
trial results may differ from real‐life data. This retrospective cross‐sectional study evaluated …

Methods: All patients had plaque psoriasis and initiated apremilast between April 1, 2015,
and September 8, 2022; patients with concurrent biologic use were excluded. Estimates of …

This real‐world study at a single academic center retrospectively examined the drug survival
of apremilast for patients with psoriasis. Retrospective information was extracted from the …

Objectives The aim of this paper is to present our personal as well as literature-sourced real-
world evidenced on apremilast use in psoriasis patients with serious baseline comorbidities …

Background Little is known about the effectiveness and drug survival associated with
apremilast under real-world conditions. Objective To investigate the influence of patient and …

Introduction The broad and sustained efficacy of apremilast for psoriasis has been
demonstrated in randomized and real-world observational studies. Data from Central and …

Background: Real-world data differ from clinical trial data. Although some real-world data
regarding apremilast use for psoriasis treatment has been reported in Western countries, no …